Danaher DHR
NYSE DHR
$212.54 +4.18 (+2.01%)
As of: Sep 17, 2026 · 3:59 PM EDT

Danaher (DHR) Revenue Growth (1y) (2010 - 2026)

Analysis

Danaher (DHR) Revenue Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 10.49%
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 5.54%
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 8.06%
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 9.44%
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 1.31%
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 1.33%
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -0.09%
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 11.93%
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -12.65%
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 5.15%
Historic Data

Historic Data

Download Data
DateValue
Jun 26, 2026 5.54%
Mar 27, 2026 3.66%
Dec 31, 2025 4.59%
Sep 26, 2025 4.40%
Jun 27, 2025 3.36%
Mar 28, 2025 -0.95%
Dec 31, 2024 2.08%
Sep 27, 2024 3.09%
Jun 28, 2024 -2.86%
Mar 29, 2024 -2.57%
Dec 31, 2023 -10.22%
Sep 29, 2023 -12.87%
Jun 30, 2023 -9.44%
Mar 31, 2023 -8.84%
Dec 31, 2022 104.00%
Sep 30, 2022 -10.71%
Jul 1, 2022 -9.56%
Apr 1, 2022 -4.84%
Dec 31, 2021 -48.27%
Oct 1, 2021 22.86%